The Swedish tradition of drug discovery and development is among the strongest in the world.
Following the growth of Pharmacia and AstraZeneca into global pharma companies, a new breed of companies is emerging in Sweden.
Some of the most successful companies offer their research and technology to new partners, clients and investors at the BIO2003 Annual Convention and Exhibition in Washington, 22-25 June.
Active Biotech
Active Biotech seeks partnerships for its novel, oral immunomodulatory drug (SAIK-MS) aimed at the treatment of patients with multiple sclerosis, as well as for use as an oral treatment for prostate cancer (TASQ). Active Biotech is also looking for collaboration partners in relation to a novel concept (TTS) for immunotherapy of cancer. Contact email
Affibody
Seeking partnerships with pharmaceutical companies for target identification and validation using Affibody´s proprietary technology. Contact email
Bioventia
Bioventia is acting as a link between innovations, financing and competent management and is currently looking for international strategic partnerships. Contact email
Biovitrum
Biovitrum is actively looking for in-licensing partners in order to strengthen its project portfolio in their core therapeutic areas: type 2 diabetes, obesity and oncology. Biovitrum also has expert knowledge and capabilities in process development and GMP manufacturing of recombinant protein drugs, which are offered to Biovitrum’s partners and customers. Contact email
Global Genomics
Introducing Tangerine, a solution for gene expression profiling that identifies virtually all active genes in a given sample. The technology can be applied within drug discovery to support target and lead identification and validation through to analysis during clinical trials. Contact email
Karo Bio
Product opportunities are Selective GR modulators and Anti-inflammatory therapeutics, Selective AR modulators in Prostate cancer, Selective TR modulators, HRT, SERMs, Dxr compound series/ Antibacterial, IspB compound series/ Antibacterial, 10 Biokey® assays/ Antibacterial. Contact email
Melacure Therapeutics
Melacure seeks partnerships with leading companies in therapeutic areas relevant to the melanocortin receptor field (MC1, MC3, MC4 and MC5) with opportunities in inflammation, obesity, diabetes and sexual dysfunction. Contact email
NeuroNova
NeuroNova is looking for strategic partnerships with pharmaceutical and biotechnology companies with an international presence in order to further the clinical development and commercialisation of its innovative therapies within its Therapeutic Neurogenesis and its Cell Transplantation Therapy programs. Contact email
Other Swedish organizations also represented at BIO2003 click relevant website link >>>
Further information on Swedish Biotechnology
Contact details for more information:
Mr. David Ernstsson, Director Swedish Bioscience Programme, Swedish Trade Council,
Cellular: +46 708 85 87 01 Contact email
Ms Clare Hobby, Swedish Bioscience Programme, Swedish Trade Council / Los Angeles,
Cellular: +1 312 925 6560 Contact email
